ESLA Estrella Immunopharma falls 392 after Q1 2026 EPS misses analyst forecasts by a wide 906 margin Illumina Inc ILMN Q1 2026 Earnings Preview Upward Analyst Revisions Signal High Probability of EPS Beat Is MGM MGM stock aligned with valuation metrics EPS misses estimates by 92 amid margin headwinds US Bancorp USB Bullish Thesis Underpins Attractive RiskReward for Core Financial Holding Is Mitsubishi MUFG stock heading higher Q1 2026 EPS Beats Forecasts GPAT GPAct III releases latest quarterly earnings management to outline full strategic outlook in upcoming investor call SUPV Grupo reports significantly wider Q4 2025 loss than expected shares post small gain Is Pembina PBA stock showing risk signals Q4 2025 Profit Exceeds Views Illumina Inc ILMN Expands Precision Oncology Collaboration Amid Robust Sector Growth Tailwinds Oriental ORIS Stock Is It Near Breakout